Physician profile
Roger Walcott
NPI 1992962302
$2,339.40
in general payments reported to CMS, 2019-2025
15 companies · $916 in 2025
The $916 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $52.11 · 2021: $24.87 · 2022: $418 · 2023: $506 · 2024: $165 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,586.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $629.25 | 2022-2025 | Endurant Iis, Valiant Captivia, Abre |
| Boston Scientific Corporation | $628.39 | 2019-2025 | Jetstream Sc, Peripheral Rotalink Plus, Eluvia |
| Medtronic Vascular, INC. | $236.19 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $167.22 | 2022-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Silk Road Medical, INC. | $166.01 | 2022 | |
| Cook Medical LLC | $109.93 | 2023 | Cook |
| Okami Medical, INC. | $108.84 | 2023 | Lobo |
| E.R. Squibb & Sons, L.L.C. | $94.75 | 2022-2025 | Eliquis, Camzyos |
| Pfizer INC. | $74.05 | 2022-2025 | |
| Smith+Nephew, INC. | $39.29 | 2022-2024 | Collagenase Santyl |
| Ethicon US, LLC | $25.32 | 2024 | Surgicel Nu-Knit |
| Lemaitre Vascular, INC. | $18.19 | 2020 | |
| Contego Medical, INC | $17.10 | 2025 | |
| Penumbra, INC. | $13.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Walcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.